Microfluidic Device-Based Virus Detection and Quantification in Future Diagnostic Research: Lessons from the COVID-19...

Area of Science:

• Biotechnology and Biomedical Engineering
• Infectious Disease Diagnostics
• Molecular Virology

Background:

• The COVID-19 pandemic exposed critical limitations in rapid diagnostic testing for highly infectious viruses.
• Existing diagnostic methods struggled to keep pace with the rapid global transmission of SARS-CoV-2.
• Millions of lives were impacted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

Purpose of the Study:

• To explore microfluidic technology and RNA-based detection for enhanced diagnostic capabilities.
• To leverage lessons learned from the COVID-19 pandemic for improved future outbreak management.
• To review the past, present, and future potential of RNA-based virus detection in pandemic preparedness.

Main Methods:

• Review of existing literature on microfluidic devices for virus detection.
• Analysis of RNA-based virus detection methods, including genetic-based approaches.
• Examination of diagnostic technology advancements in the context of the COVID-19 pandemic.

Main Results:

• Microfluidic devices have demonstrated potential for effective detection and quasi-quantification of viruses like HIV, influenza, and SARS-CoV-2.
• The COVID-19 pandemic highlighted a significant need for quantitative rapid tests to assess infectiousness.
• Microfluidics presents a promising alternative to current rapid tests for managing highly virulent diseases.

Conclusions:

• Microfluidic technology, particularly RNA-based detection, is crucial for advancing diagnostic capabilities.
• Integrating microfluidics can improve outbreak management and preparedness for future pandemic-level threats.
• Continued development in this area is essential for more effective global health security.